{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:30Z","timestamp":1792089990084,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"Abstract<\/jats:title>\n \n Introduction<\/jats:title>\n Given the significant role of the gut microbiota in early immune and metabolic development, the impact of perinatal antibiotic administration on the neonatal gut microbiome remains a crucial area of investigation. This study examines how maternal and neonatal antibiotic exposure affects the composition of the gut microbiome in preterm infants.<\/jats:p>\n <\/jats:sec>\n \n Methodology<\/jats:title>\n A prospective controlled cohort study was conducted in the neonatal intensive care unit of a tertiary care hospital from January 2021 to September 2023. The study enrolled neonates with a gestational age of less than 37 weeks. Preterm infants were categorized into four groups based on exposure to maternal or neonatal antibiotics: the NE group (no exposure), IE group (infant exposure only), ME group (maternal exposure only), and IME group (both infant and maternal exposure). In the NE group, \u201cNo exposure\u201d refers to participants whose mothers did not receive intrapartum antibiotics or whose neonates were not administered postnatal antibiotics prior to sample collection. Data on antibiotic use and microbiota composition from stool samples were collected and analyzed via the convection culture method.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n This study included 182 preterm infants, yielding 364 stool samples. By day 4, the prevalence of\n Klebsiella pneumoniae<\/jats:italic>\n increased significantly, reaching 70% in the IE group compared with 42.6% in the NE group (\n p<\/jats:italic>\n \u2009<\u20090.001).\n Bifidobacterium spp<\/jats:italic>\n . was more prevalent in the NE group than in the other groups on day 4 (57.4%,\n p<\/jats:italic>\n \u2009=\u20090.019). The antibiotic-exposed groups (IE, ME, and IME groups) presented greater abundances of potentially pathogenic bacteria, such as\n Klebsiella pneumoniae<\/jats:italic>\n and\n Escherichia coli<\/jats:italic>\n , whereas beneficial bacteria, such as\n Bifidobacterium<\/jats:italic>\n spp., were more abundant in the NE group.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n These findings suggest that perinatal antibiotic exposure is associated with significant changes in the neonatal gut microbiota, potentially increasing the pathogenic microbiota.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n \n The study was registered with the Clinical Trials Registry-India (CTRI) under the number CTRI\/2020\/11\/029375 |\n http:\/\/ctri.nic.in\/<\/jats:ext-link>\n on November 19, 2020.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1186\/s12887-025-05907-y","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T02:44:00Z","timestamp":1753065840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Influence of perinatal antibiotic on neonatal gut microbiota: a prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1335-1796","authenticated-orcid":false,"given":"Faiza","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6781-5579","authenticated-orcid":false,"given":"Padmaja A.","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3467-6821","authenticated-orcid":false,"given":"Leslie Edward S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4320-7904","authenticated-orcid":false,"given":"N.","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9754-1756","authenticated-orcid":false,"given":"Jayashree","family":"Purkayastha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7561-4435","authenticated-orcid":false,"given":"Vandana Kalwaje","family":"Eshwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"2","key":"5907_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/antibiotics12020258","volume":"12","author":"C Morreale","year":"2023","unstructured":"Morreale C, Giaroni C, Baj A, Folgori L, Barcellini L, Dhami A, et al. Effects of perinatal antibiotic exposure and neonatal gut microbiota. Antibiotics. 2023;12(2):258.","journal-title":"Antibiotics"},{"issue":"11","key":"5907_CR2","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3390\/ph16111615","volume":"16","author":"G Muteeb","year":"2023","unstructured":"Muteeb G, Rehman MT, Shahwan M, Aatif M. Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review. Pharmaceuticals. 2023;16(11):1615.","journal-title":"Pharmaceuticals"},{"issue":"16","key":"5907_CR3","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.3390\/nu15163647","volume":"15","author":"AC Pantazi","year":"2023","unstructured":"Pantazi AC, Balasa AL, Mihai CM, Chisnoiu T, Lupu VV, Kassim MAK, et al. Development of gut microbiota in the first 1000 days after birth and potential interventions. Nutrients. 2023;15(16):3647.","journal-title":"Nutrients"},{"issue":"5","key":"5907_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/antibiotics12050831","volume":"12","author":"C Gamberini","year":"2023","unstructured":"Gamberini C, Donders S, Al-Nasiry S, Kamenshchikova A, Ambrosino E. Antibiotic use in pregnancy: a global survey on antibiotic prescription practices in antenatal care. Antibiotics. 2023;12(5):831.","journal-title":"Antibiotics"},{"key":"5907_CR5","doi-asserted-by":"publisher","first-page":"101245","DOI":"10.1016\/j.cegh.2023.101245","volume":"20","author":"F Iqbal","year":"2023","unstructured":"Iqbal F, Lewis LES, Siva N, Purkayastha KeV, Shenoy J. Modulation of gut microbiota: an emerging consequence in neonatal sepsis. Clin Epidemiol Glob Health. 2023;20:101245.","journal-title":"Clin Epidemiol Glob Health"},{"issue":"1","key":"5907_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.1260","volume":"11","author":"DV Patangia","year":"2022","unstructured":"Patangia DV, Anthony Ryan C, Dempsey E, Paul Ross R, Stanton C. Impact of antibiotics on the human microbiome and consequences for host health. Microbiol Open. 2022;11(1): e1260.","journal-title":"Microbiol Open"},{"issue":"4","key":"5907_CR7","first-page":"489","volume":"42","author":"H Neuman","year":"2018","unstructured":"Neuman H, Forsythe P, Uzan A, Avni O, Koren O. Antibiotics in early life: dysbiosis and the damage done. FEMS Microbiol Rev. 2018;42(4):489\u201399.","journal-title":"FEMS Microbiol Rev"},{"issue":"3","key":"5907_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/jac\/dkx426","volume":"73","author":"JW Fjalstad","year":"2018","unstructured":"Fjalstad JW, Esaiassen E, Juvet LK, van den Anker JN, Klingenberg C. Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review. J Antimicrob Chemother. 2018;73(3):569\u201380.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"5907_CR9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/phar.2732","volume":"43","author":"SP Thomas","year":"2023","unstructured":"Thomas SP, Denizer E, Zuffa S, Best BM, Bode L, Chambers CD, et al. Transfer of antibiotics and their metabolites in human milk: implications for infant health and microbiota. Pharmacotherapy. 2023;43(5):442\u201351.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"5907_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.chom.2020.08.001","volume":"28","author":"MR Asbury","year":"2020","unstructured":"Asbury MR, Butcher J, Copeland JK, Unger S, Bando N, Comelli EM, et al. Mothers of preterm infants have individualized breast milk microbiota that changes temporally based on maternal characteristics. Cell Host Microbe. 2020;28(5):669\u2013e6824.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"5907_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41467-022-28525-z","volume":"13","author":"M Reyman","year":"2022","unstructured":"Reyman M, van Houten MA, Watson RL, Chu MLJN, Arp K, de Waal WJ, et al. Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial. Nat Commun. 2022;13(1):893.","journal-title":"Nat Commun"},{"issue":"4","key":"5907_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.wombi.2017.10.012","volume":"31","author":"K Braye","year":"2018","unstructured":"Braye K, Ferguson J, Davis D, Catling C, Monk A, Foureur M. Effectiveness of intrapartum antibiotic prophylaxis for early-onset group B Streptococcal infection: an integrative review. Women Birth. 2018;31(4):244\u201353.","journal-title":"Women Birth"},{"key":"5907_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jare.2022.11.004","volume":"51","author":"Q Xiang","year":"2022","unstructured":"Xiang Q, Yan X, Shi W, Li H, Zhou K. Early gut microbiota intervention in premature infants: application perspectives. J Adv Res. 2022;51:59\u201372.","journal-title":"J Adv Res"},{"issue":"4","key":"5907_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.alit.2017.07.010","volume":"66","author":"M Tanaka","year":"2017","unstructured":"Tanaka M, Nakayama J. Development of the gut microbiota in infancy and its impact on health in later life. Allergol Int. 2017;66(4):515\u201322.","journal-title":"Allergol Int"},{"issue":"2","key":"5907_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/life11020148","volume":"11","author":"A Coscia","year":"2021","unstructured":"Coscia A, Bardanzellu F, Caboni E, Fanos V, Peroni DG. When a neonate is born, so is a microbiota. Life. 2021;11(2):148.","journal-title":"Life"},{"issue":"1","key":"5907_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41390-021-01494-7","volume":"91","author":"S Ainonen","year":"2022","unstructured":"Ainonen S, Tejesvi MV, Mahmud MR, Paalanne N, Pokka T, Li W, et al. Antibiotics at birth and later antibiotic courses: effects on gut microbiota. Pediatr Res. 2022;91(1):154\u201362.","journal-title":"Pediatr Res"},{"issue":"23","key":"5907_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182312621","volume":"18","author":"A Cantarutti","year":"2021","unstructured":"Cantarutti A, Rea F, Franchi M, Beccalli B, Locatelli A, Corrao G. Use of antibiotic treatment in pregnancy and the risk of several neonatal outcomes: a population-based study. Int J Environ Res Public Health. 2021;18(23): 12621.","journal-title":"Int J Environ Res Public Health"},{"key":"5907_CR18","unstructured":"Mayo Clinic. What antibiotics are safe during pregnancy? Available from: https:\/\/www.mayoclinic.org\/healthy-lifestyle\/pregnancy-week-by-week\/expert-answers\/antibiotics-and-pregnancy\/faq-20058542. [cited 2024 Apr 20]."},{"issue":"70 Suppl 1","key":"5907_CR19","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/cid\/ciz1231","volume":"70","author":"PA Yu","year":"2020","unstructured":"Yu PA, Tran EL, Parker CM, Kim HJ, Yee EL, Smith PW, et al. Safety of antimicrobials during pregnancy: a systematic review of antimicrobials considered for treatment and postexposure prophylaxis of plague. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;70(70 Suppl 1):S37\u201350.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"5907_CR20","first-page":"76","volume":"115","author":"PS Padberg","year":"2015","unstructured":"Padberg P S. Anti-infective agents. Drugs Pregnancy Lact. 2015;115:76.","journal-title":"Drugs Pregnancy Lact"},{"issue":"10","key":"5907_CR21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1080\/17425255.2021.1974000","volume":"17","author":"W Qu","year":"2021","unstructured":"Qu W, Liu L, Miao L. Exposure to antibiotics during pregnancy alters offspring outcomes. Expert Opin Drug Metab Toxicol. 2021;17(10):1165\u201374.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"5907_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41467-020-20495-4","volume":"12","author":"A Uzan-Yulzari","year":"2021","unstructured":"Uzan-Yulzari A, Turta O, Belogolovski A, Ziv O, Kunz C, Perschbacher S, et al. Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization. Nat Commun. 2021;12(1):443.","journal-title":"Nat Commun"},{"issue":"12","key":"5907_CR23","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41564-019-0550-2","volume":"4","author":"AJ Gasparrini","year":"2019","unstructured":"Gasparrini AJ, Wang B, Sun X, Kennedy EA, Hernandez-Leyva A, Ndao IM, et al. Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome. Nat Microbiol. 2019;4(12):2285\u201397.","journal-title":"Nat Microbiol"},{"key":"5907_CR24","doi-asserted-by":"crossref","unstructured":"Stokholm J, Schj\u00f8rring S, Pedersen L, Bischoff AL, F\u00f8lsgaard N, Carson CG et al. Prevalence and predictors of antibiotic administration during pregnancy and birth. PLoS ONE. 2013;8(12). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3858309\/. [cited 2024 Apr 17].","DOI":"10.1371\/journal.pone.0082932"},{"issue":"4","key":"5907_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/antibiotics11040470","volume":"11","author":"Y Kwon","year":"2022","unstructured":"Kwon Y, Cho YS, Lee YM, Kim S, jin, Bae J, Jeong SJ. Changes to gut microbiota following systemic antibiotic administration in infants. Antibiotics. 2022;11(4):470.","journal-title":"Antibiotics"},{"issue":"5","key":"5907_CR26","first-page":"081","volume":"13","author":"P Chandra","year":"2023","unstructured":"Chandra P, Iqbal F, Unnikrisnan MK, Jayashree P, Shenoy PA, Anburaj SE, et al. Neonatal outcomes associated with antimicrobial resistance: a retrospective cross-sectional study. J Appl Pharm Sci. 2023;13,(5):081\u201394.","journal-title":"J Appl Pharm Sci"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05907-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05907-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05907-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:01:00Z","timestamp":1757260860000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05907-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5907"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05907-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of Kasturba Medical College and Kasturba Hospital (Approval number [IEC:490\/2020]) and followed the ethical guidelines of the 1975 Declaration of Helsinki. All parents or legal guardians in the study signed a written informed consent before participation. As patients were minors, parental written consent were obtained. The physical records are stored at the Kasturba medical college, Manipal Academy of higher Education, Manipal, Department of Paediatric.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"560"}}